3,3'-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,1'-biphenyl, 97%, 5g

5,7-DICHLORO-1H-PYRAZOLO[4,3-D]PYRIMIDINE, 97%, 50mg

(R)-1-(4-Morpholinophenyl)ethan-1-ol, 98%, 1g

Boric acid solution 4%, pa, 2.5 l, plastic packaging.

5-Bromo-2-chloro-3-fluorophenol, 95.0%, 250mg

((2R,3S,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, 98%, 250mg

Methyl alpha-D-Galactopyranoside Monohydrate>98.0%(GC)25g

1-(6-Chloro-1H-benzo[d]imidazol-2-yl)guanidine, 98%, 100mg

(4R)-2,2-Dimethyl-4-thiazolidinecarboxylic Acid, 98%, 1g

Pyrazine-2,5-dicarbaldehyde, 95%, 50mg

1-(5-Fluoropyridin-3-yl)propan-1-one, 97%, 1g

1-(Thiophene-2-sulfonyl)-piperidine-3-carboxylic acid, 95.0%, 1g

3-METHYL-5-NITRO-1H-INDAZOLE, 95%, 25g